Gene amplification technology has been a backbone technology for the Human Genome Project and is vital in other fields, such as diagnostics. There are more than 50 biotech and diagnostic companies with DNA amplification technology and approximately 30 different gene- and signal-amplification technologies, from polymerase chain reaction to ligase chain reaction, transcription mediated amplification, and dendritic polymers. And these many technologies are being used for an ever-increasing variety of applications in research and clinical settings.
The market for amplification technology is currently in the hundreds of millions of dollars, but as the need for information about genes in genomics and other research progresses, and as clinical diagnostic tools develop, the market for amplification technology will continue to grow. Although PCR is currently the dominant amplification technology, other technologies are emerging to challenge PCR in many areas. Patents, costs, and ease of use of a technique are forces that drive the development of amplification technology and will shape this dynamic market.
This study reviews the landscape in this emerging sector, discussing technologies, applications, competitors, and regulation. In addition, Kalorama has conducted the first ever end-user survey, to determine the preferences of actual researchers using various amplification technologies in various settings and for various applications.
Gene Amplification Revenues to Surpass $1.6 Billion by 2007
New York, August 6, 2002 /PR Newswire — Applications and revenues will continue to expand for gene amplification technologies, according to a new study released today from Kalorama Information. The study found that total revenues for the top ten amplification technologies will grow by more than 50% from their current levels to surpass $1.6 billion in 2007.
The new study, Gene Amplification Technologies: End Users, Marketers, and Markets, also found that although the polymerase chain reaction (PCR) has long been the dominant technology in the field, it is no longer the only one deriving significant revenues. According to the report, several other techniques, including OmniPlex (Rubicon Genomics), SDA (Becton Dickinson), LCR (Abbott/ImClone), and Hybrid Capture (Digene), are growing at double-digit rates and making progress in specific applications.
In addition to quantifying the market, part of the study involved surveying the attitudes of end-users working with amplification techniques. The study sought to define some of the strategies marketers will need to adopt to compete in a PCR-dominated field that is nonetheless experiencing dynamic technical advancement. Researchers are beginning to use different technologies for some applications, according to the results, but the lack of robust technical trouble-shooting experience was a major drawback for many non-PCR techniques.
“Isothermal DNA amplification techniques, such as rolling circle, are attractive because they would be faster and do not require the use of a thermocycler machine,” notes Laura Ruth, PhD, the author of the study. “However, users indicated that they are wary because not as much is known about isothermal DNA amplification techniques.”
The study discusses trends in target versus signal amplification, isothermal versus cycling temperature, and exponential versus linear technologies, as well as the future of the field and the potential development of chip-based technologies.
About Kalorama Information
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or email@example.com.
MarketResearch.com is the leading provider of global market intelligence products and services. With over 50,000 research publications from 350 research publishers, they offer instant online access to the world’s most extensive database of expert insights on global industries. Updated daily. For more information, contact Kim Bolus at 212-807-2655 or firstname.lastname@example.org.